Im interested in the processes and mechanisms behind the regulation of gene expression, especially on the level of RNA, RNA secondary structure and the plethora of interactions shaping this level. The recent advent of personalized medicine as a field involving huge amounts of data, particularly from high-throughput sequencing, opens new paths for investigations into the roles of RNA regulatory factors as disease initiators and progressors. My interest in non-coding RNAs as such regulators extends from Alzheimer's disease to cancer drivers and biomarker identification.